ACTIONS OF THE ENDOCANNABINOID TRANSPORT INHIBITOR AM404 IN NEUROPATHIC AND INFLAMMATORY PAIN MODELS

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1681.2007.04692.xPMID 17880375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

  2006influential reference
• Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]

  2006influential reference
• AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain

  2006influential reference
• Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

  2006cited by this paper
• AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.

  2005cited by this paper
• Identification of a high-affinity binding site involved in the transport of endocannabinoids.

  2005cited by this paper
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cited by this paper
• Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

  2005cited by this paper
• 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects

  2004cited by this paper
• Repeated treatment with the synthetic cannabinoid WIN 55,212‐2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain

  2004cited by this paper
• Evidence that CB‐1 and CB‐2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat

  2004cited by this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004cited by this paper
• Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

  2004cited by this paper
• A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain

  2003cited by this paper
• Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics

  2003cited by this paper
• Upregulation of spinal cannabinoid‐1‐receptors following nerve injury enhances the effects of Win 55,212‐2 on neuropathic pain behaviors in rats

  2003cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper
• Cellular accumulation of anandamide: consensus and controversy

  2003cited by this paper
• Evidence against the presence of an anandamide transporter

  2003cited by this paper
• CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

  2002cited by this paper
• Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons

  2002cited by this paper
• The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

  2001cited by this paper
• Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

  2001cited by this paper
• Cannabinoid CB1 receptor upregulation in a rat model of chronic neuropathic pain

  2001cited by this paper
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

  2001cited by this paper
• Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic pain.

  2001cited by this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cited by this paper
• Structure—Activity Relationships Among N‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter

  2000cited by this paper
• The anandamide transport inhibitor AM404 activates vanilloid receptors.

  2000cited by this paper
• Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

  2000cited by this paper
• Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.

  2000cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

  1999cited by this paper
• Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

  1998cited by this paper
• Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Characterization of Δ9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

  1998cited by this paper
• The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.

  1997cited by this paper
• Comparison of three rodent neuropathic pain models

  1997cited by this paper
• Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

  1997cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury

  1990cited by this paper

• Dual effects of anandamide in the antiepileptic activity of diazepam in pentylenetetrazole-induced seizures in mice

  2022cites this paper
• On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence

  2021cites this paper
• Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model

  2021cites this paper
• Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation

  2020cites this paper
• Mechanism of Action, Kinetics and a Bioactive Metabolites AM404 of Paracetamol

  2020cites this paper
• Paracetamol – An old drug with new mechanisms of action

  2020cites this paper
• Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity

  2019cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper
• Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymes.

  2019cites this paper
• The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors

  2018cites this paper
• Enhanced endocannabinoid tone as a potential target of pharmacotherapy

  2018cites this paper
• Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy

  2018cites this paper
• An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice.

  2017cites this paper
• AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity

  2017cites this paper
• Acetaminophen Metabolite N-Acylphenolamine Induces Analgesia via Transient Receptor Potential Vanilloid 1 Receptors Expressed on the Primary Afferent Terminals of C-fibers in the Spinal Dorsal Horn.

  2017cites this paper
• The cannabinoid system and its role in nociception

  2016cites this paper
• Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase

  2015cites this paper
• Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.

  2013cites this paper
• The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

  2013cites this paper
• Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

  2012cites this paper
• Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures.

  2012cites this paper
• Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor.

  2012cites this paper
• Investigating the role of the endogenous cannabinoid system in emotional modulation of pain: neurochemical and molecular mechanisms

  2012influential citation
• Paracetamol-Induced Hypothermia Is Independent of Cannabinoids and Transient Receptor Potential Vanilloid-1 and Is Not Mediated by AM404

  2011cites this paper
• The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.

  2011cites this paper
• Analysis of the role of cannabinoid receptors and 2-adrenoceptor subtypes in gastrointestinal functions

  2011cites this paper
• nvolvement of endocannabinoids in antidepressant and anti-compulsive effect f fluoxetine in mice

  2011cites this paper
• TRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception

  2010cites this paper
• Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol.

  2010cites this paper
• Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.

  2009cites this paper
• Inactivation and Biotransformation of the Endogenous Cannabinoids Anandamide and 2-Arachidonoylglycerol

  2009cites this paper
• Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats

  2009cites this paper
• The endocannabinoid system and pain.

  2009cites this paper
• Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation

  2009cites this paper
• Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

  2009cites this paper
• Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

  2009cites this paper
• he endocannabinoid transport inhibitor AM 404 modulates ociception in cholestasis

  2009cites this paper
• Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non‐cannabinoid receptor‐mediated mechanisms

  2008cites this paper
• Mechanisms of AM404-induced [Ca(2+)](i) rise and death in human osteosarcoma cells.

  2008cites this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cites this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cites this paper